L01XA03 |
B |
Oxaliplatin - 50mg/10ml |
5150 |
23718/06 |
ELOXATIN |
50mg/10ml |
1 x 10ml |
Injectable concentrated solution |
Infusion |
Mersaco |
Sanofi Aventis Deutschland GmbH |
Germany |
4,930,558 L.L |
23.08 |
B |
Sanofi Aventis |
France |
12/12/20 |
0 |
L01XA03 |
G |
Oxaliplatin - 50mg |
6325 |
221167/08 |
OXALTIE |
50mg |
1 |
Injectable lyophilised powder for solution |
Infusion |
New Europharm |
Bioprofarma S.A. |
Argentine |
2,957,797 L.L |
23.08 |
B |
Bioprofarma S.A. |
Argentine |
12/12/20 |
0 |
L01XA03 |
G |
Oxaliplatin - 50mg |
8487 |
99415/1 |
OXALIPLATIN MEDAC |
50mg |
1 |
Injectable powder for solution |
Infusion |
Mersaco |
Medac Gesellschaft Fur Klinische Spezialpraparate mbH |
Germany |
3,440,237 L.L |
23.08 |
B |
Medac Gesellschaft Fur Klinische Spezialpraparate mbH |
Germany |
12/12/20 |
0 |
L01XA03 |
G |
Oxaliplatin - 50mg |
10660 |
12821 |
OXALTIE |
50mg |
1 |
Injectable lyophilised powder |
Infusion |
New Europharm |
Laboratorio Kemex SA |
Argentine |
2,957,797 L.L |
23.08 |
B |
Bioprofarma Bago SA |
Argentine |
12/12/20 |
0 |
L01XA03 |
G |
Oxaliplatin - 50mg/10ml |
11522 |
20420/1 |
OXALIPLATIN EBEWE |
50mg/10ml |
1 x 10ml |
Injectable concentrated solution |
Infusion |
Khalil Fattal & Fils S.A.L. |
Fareva Unterach GmbH |
Austria |
3,405,297 L.L |
23.08 |
B |
Sandoz Pharmaceuticals AG |
Switzerland |
12/12/20 |
0 |
L01XA03 |
G |
Oxaliplatin - 50mg |
6384 |
218855/09 |
OXALIPLATINE VIATRIS 5MG/ML |
50mg |
1 |
Injectable powder for solution |
Infusion |
Benta Trading Co s.a.l. |
Benta SAL under license from Viatris Santé, France |
Lebanon |
4,032,662 L.L |
23.08 |
B |
|
|
12/12/20 |
0 |